IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TRIGGIANI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.021
AS - Asia 3.727
EU - Europa 3.285
SA - Sud America 628
Continente sconosciuto - Info sul continente non disponibili 253
AF - Africa 84
OC - Oceania 13
Totale 16.011
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.834
SG - Singapore 1.303
CN - Cina 1.068
IT - Italia 727
PL - Polonia 496
BR - Brasile 494
DE - Germania 453
HK - Hong Kong 402
UA - Ucraina 387
VN - Vietnam 275
FI - Finlandia 245
FR - Francia 198
GB - Regno Unito 187
BD - Bangladesh 184
RU - Federazione Russa 138
TR - Turchia 138
IN - India 116
BE - Belgio 106
IE - Irlanda 100
CA - Canada 93
MX - Messico 53
ID - Indonesia 45
AR - Argentina 42
IQ - Iraq 40
CZ - Repubblica Ceca 39
ES - Italia 39
NL - Olanda 35
SE - Svezia 31
ZA - Sudafrica 31
EC - Ecuador 28
JP - Giappone 28
CO - Colombia 20
SA - Arabia Saudita 18
MA - Marocco 16
AT - Austria 15
VE - Venezuela 15
PK - Pakistan 14
GR - Grecia 13
UZ - Uzbekistan 13
LT - Lituania 12
AU - Australia 11
DZ - Algeria 11
AE - Emirati Arabi Uniti 10
AL - Albania 9
JM - Giamaica 9
CL - Cile 8
EG - Egitto 8
HU - Ungheria 8
TN - Tunisia 8
BO - Bolivia 7
PY - Paraguay 7
EU - Europa 6
JO - Giordania 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
CH - Svizzera 5
IL - Israele 5
KH - Cambogia 5
NP - Nepal 5
PT - Portogallo 5
TH - Thailandia 5
AM - Armenia 4
BY - Bielorussia 4
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
PE - Perù 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
CY - Cipro 3
HN - Honduras 3
IR - Iran 3
KR - Corea 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
BG - Bulgaria 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
IS - Islanda 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
Totale 15.748
Salva come PNG Salva come JPEG
Città #
Ashburn 912
Singapore 707
Fairfield 701
Warsaw 487
Woodbridge 442
San Jose 412
Hong Kong 397
Houston 350
Seattle 313
Chandler 312
New York 292
Cambridge 288
Jacksonville 283
Wilmington 244
Beijing 235
The Dalles 233
Los Angeles 213
Helsinki 192
Ann Arbor 189
Princeton 165
Dallas 160
Dearborn 146
Brescia 121
Munich 121
Council Bluffs 115
Istanbul 104
Lauterbourg 103
Dublin 97
Ho Chi Minh City 90
Leuven 90
Shanghai 81
Milan 75
Nanjing 74
Santa Clara 69
San Francisco 58
Columbus 53
Buffalo 51
Des Moines 51
Dong Ket 46
Moscow 45
São Paulo 45
Chicago 42
Hanoi 42
Redondo Beach 42
Boardman 39
Orem 39
San Diego 38
Frankfurt am Main 36
Denver 34
Montreal 34
Washington 34
Jakarta 33
London 33
Chennai 32
Brno 29
Nanchang 29
Turku 29
Brooklyn 28
Shenyang 28
Changsha 25
Jinan 23
Phoenix 23
Tokyo 22
Boston 21
Nuremberg 21
Poplar 21
Hebei 20
Mexico City 20
Verona 19
Zhengzhou 19
Atlanta 18
Johannesburg 18
Toronto 18
Baghdad 17
Rome 17
Brussels 16
Kunming 16
Naples 16
Tianjin 16
Bari 15
Rio de Janeiro 15
Romola 15
Quito 14
Stockholm 14
Haiphong 13
Jiaxing 13
Barcelona 12
Charlotte 12
Da Nang 12
Hangzhou 12
Lancaster 12
Ningbo 12
Tashkent 12
Ankara 11
Athens 11
Belo Horizonte 11
New Delhi 11
Ribeirão Preto 11
Amsterdam 10
Brasília 10
Totale 10.427
Salva come PNG Salva come JPEG
Nome #
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 284
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 271
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 253
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 251
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 251
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 229
Pros-IT CNR: an Italian prostate cancer monitoring project 225
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 224
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 221
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 216
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 213
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 213
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 211
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 200
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 194
GUROPA survey: genito-urinary radiation oncology prescription attitudes 194
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 193
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 189
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 186
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 180
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 179
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 177
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 176
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 176
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 174
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 174
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 172
Role of external beam radiotherapy in the treatment of relapsing meningioma 172
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 169
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 168
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 166
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 166
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 165
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 163
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 163
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 163
From Molecular to Clinical Radiation Biology of Glioblastoma 161
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 160
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 159
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 157
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 157
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 157
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 149
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 148
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 146
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 145
Cetuximab and Radiation Therapy in Head and Neck Cancer 145
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 145
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 143
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy 143
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 142
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 142
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 141
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 140
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 140
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 136
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 135
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 135
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 134
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 133
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 130
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 129
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 129
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 125
Applying radiation protection and safety in radiotherapy 122
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 122
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 118
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 115
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 114
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 112
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 110
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 110
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 110
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 109
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 107
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 106
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 105
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 103
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 103
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 102
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 100
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 99
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 99
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 97
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 93
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 91
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP) 90
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 87
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 86
Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation 85
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 85
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 84
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 84
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 83
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group 83
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START) 83
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 83
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: A view of the nation's young oncologists 82
Totale 14.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022686 0 100 26 28 12 49 31 67 39 83 38 213
2022/2023878 97 35 34 52 90 186 13 106 157 5 64 39
2023/20241.371 69 28 165 75 71 302 50 89 206 49 65 202
2024/20252.275 33 35 29 340 180 208 190 117 249 160 449 285
2025/20265.522 516 610 388 714 619 361 800 206 382 472 253 201
2026/2027340 179 161 0 0 0 0 0 0 0 0 0 0
Totale 16.011